PubMed:24691501 / 1474-1636
Annnotations
c_corpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T215 | 17-24 | C552206 | denotes | BXL0124 |
| T216 | 17-24 | C552206 | denotes | BXL0124 |
| T219 | 47-51 | SO:0000234 | denotes | mRNA |
| T217 | 47-51 | D012333 | denotes | mRNA |
| T218 | 47-51 | CHEBI:33699 | denotes | mRNA |
| T220 | 62-68 | UBERON:0027368 | denotes | matrix |
| T221 | 62-87 | D020782 | denotes | matrix metalloproteinases |
| T223 | 151-161 | SO:1000009 | denotes | transition |
UseCases_ArguminSci_Discourse
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T12 | 0-162 | DRI_Approach | denotes | In addition, the BXL0124 treatment reduced the mRNA levels of matrix metalloproteinases starting at week 3, contributing to the inhibition of invasive transition. |
PubMed_ArguminSci
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T10 | 0-162 | DRI_Approach | denotes | In addition, the BXL0124 treatment reduced the mRNA levels of matrix metalloproteinases starting at week 3, contributing to the inhibition of invasive transition. |